Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Current Leases: 2019-2025

Historic Current Leases for Amphastar Pharmaceuticals (AMPH) over the last 7 years, with Sep 2025 value amounting to $7.8 million.

  • Amphastar Pharmaceuticals' Current Leases rose 85.96% to $7.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.8 million, marking a year-over-year increase of 85.96%. This contributed to the annual value of $6.8 million for FY2024, which is 74.19% up from last year.
  • According to the latest figures from Q3 2025, Amphastar Pharmaceuticals' Current Leases is $7.8 million, which was down 0.66% from $7.9 million recorded in Q2 2025.
  • In the past 5 years, Amphastar Pharmaceuticals' Current Leases ranged from a high of $7.9 million in Q2 2025 and a low of $2.9 million during Q3 2021.
  • Moreover, its 3-year median value for Current Leases was $4.0 million (2024), whereas its average is $5.1 million.
  • Its Current Leases has fluctuated over the past 5 years, first dropped by 21.35% in 2021, then surged by 97.17% in 2025.
  • Over the past 5 years, Amphastar Pharmaceuticals' Current Leases (Quarterly) stood at $3.0 million in 2021, then climbed by 0.70% to $3.0 million in 2022, then soared by 30.07% to $3.9 million in 2023, then surged by 74.19% to $6.8 million in 2024, then surged by 85.96% to $7.8 million in 2025.
  • Its Current Leases was $7.8 million in Q3 2025, compared to $7.9 million in Q2 2025 and $7.7 million in Q1 2025.